Hoechst Marion Roussel Refludan
Executive Summary
Anticoagulant lepirudin (rDNA) for injection approved March 6 for patients with heparin-induced thrombocytopenia and thromboembolic disease to prevent further thromboembolic complications. The agent was approved as an orphan drug under a priority review after being deemed "approvable" Sept. 8...